The pharmaceutical industry is absolutely agreeing on the Exclusive Sale Rights Policy

Published: 2014-12-19 11:06:16

Updated: 2014-12-19 11:06:16

The Pharmaceutical Policy Committee of the Korea Pharmaceutical Manufacturers Association (KPMA), researching and discussing about legislations and policies among pharmaceutical companies,recently held a meeting to conduct a survey for the controversial issue of the Exclusive Sale Rights Policy.

The committee is formed with 13 different large and mid-sized pharmaceutical companies. The purpose...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.